Loading institutional data...
Loading institutional data...
Held by 209 of 5,944 reporting institutions (92th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Ranked against 235 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WMT | $896.8B | 41.1× | — | 1.3× | 4.7% | 24.9% | 3.1% | 22.0% | 15.5% | — | 4,273 |
| COST | $417.5B | 51.7× | 31.9× | 1.5× | 8.2% | 12.8% | 2.9% | 27.8% | 23.2% | 0.4× | 4,050 |
| KO | $373.6B | 28.6× | 24.5× | 7.8× | 1.9% | 61.6% | 27.3% | 40.7% | 40.7% | — | 3,427 |
| PG | $345.0B | 22.6× | 16.3× | 4.1× | 0.3% | 51.2% | 19.0% | 30.6% | 18.4% | 1.5× | 3,849 |
| PM | $294.0B | 26.0× | 17.1× | 7.2× | 7.3% | 67.1% | 27.9% | -114% | -115% | 0.0× | 2,744 |
| PEP | $190.0B | 23.1× | 15.4× | 2.0× | 2.3% | 54.1% | 8.8% | 40.4% | 11.8% | 3.3× | 3,404 |
| BUDFF | $151.5B | — | — | — | — | — | — | — | — | — | 5 |
| UNLYF | $138.7B | — | — | — | — | — | — | — | — | — | 23 |
| MO | $114.6B | 16.6× | 13.2× | 4.9× | -3.1% | 62.5% | 29.8% | -198% | 33.7% | 2.4× | 2,375 |
| MNST | $92.4B | — | 35.6× | 11.1× | 10.7% | 55.8% | 23.0% | 23.1% | 23.1% | — | 1,169 |
| MDLZ | $81.0B | 33.1× | 19.0× | 2.1× | 5.8% | 28.4% | 6.4% | 9.5% | 8.6% | 0.6× | 1,821 |
| CL | $74.7B | 35.5× | 20.4× | 3.7× | 1.4% | 60.1% | 10.5% | 3948% | 30.8% | 1.7× | 1,873 |
| TGT | $66.9B | 18.2× | 9.8× | 0.6× | -1.7% | 27.9% | 3.5% | 22.9% | 12.1% | 1.7× | 1,771 |
| DGEAF | $54.3B | — | — | — | — | — | — | — | — | — | 4 |
| CCEP | $48.8B | — | — | — | — | — | — | — | — | — | 543 |
| ABEV | $47.8B | — | — | — | — | — | — | — | — | — | 383 |
| JBS | $45.1B | — | — | — | — | — | — | — | — | — | 241 |
| FMX | $42.4B | — | — | — | — | — | — | — | — | — | 290 |
| KDP | $41.8B | 20.1× | 14.1× | 2.5× | 8.2% | 54.2% | 12.5% | 8.1% | 5.0% | 4.0× | 784 |
| SYY | $41.1B | 22.6× | 10.3× | 0.5× | 3.2% | 18.4% | 2.2% | 99.9% | 99.9% | — | 1,489 |
| KVUE | $37.7B | 25.9× | 15.7× | 2.5× | -2.1% | 58.1% | 9.7% | 13.7% | 7.1% | 3.4× | 967 |
| ADM | $37.6B | 34.8× | — | 0.5× | -6.2% | 6.3% | 1.3% | 4.7% | 3.6% | — | 1,070 |
| KMB | $37.3B | 18.5× | 11.8× | 2.3× | -2.1% | 36.0% | 12.3% | 135% | 92.0% | 0.2× | 1,585 |
| KR | $37.0B | 36.8× | 9.2× | 0.3× | 0.4% | — | 0.7% | 17.1% | 5.0% | 2.8× | 1,327 |
| HSY | $36.4B | — | 21.2× | 3.1× | 4.4% | 33.5% | 7.6% | 19.0% | 9.3% | 2.5× | 1,406 |
| EPC | $1.4B | 55.1× | 14.8× | 0.6× | -1.3% | 41.6% | 1.1% | 1.6% | 0.9% | 7.5× | 209 |
Peers = companies sharing EPC's sector (Consumer Defensive) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
EOD close · as of 2026-08-05 · 15d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.22B 100.0% | $2.25B 100.0% | $2.25B 100.0% | $2.17B 100.0% | $2.09B 100.0% | $1.95B 100.0% | $2.14B 100.0% | $2.23B 100.0% | $2.30B 100.0% | $2.36B 100.0% |
| Cost of Revenue | $1.30B 58.4% | $1.30B 57.6% | $1.31B 58.2% | $1.29B 59.5% | $1.14B 54.4% | $1.07B 54.8% | $1.17B 54.9% | $1.20B 53.8% | $1.17B 51.0% | $1.20B 50.9% |
| Cost of Products | — | — | — | — | — | — | — | $1.20B 53.6% | $1.17B 50.8% | $1.20B 50.9% |
| Gross Profit | $924.9M 41.6% | $955.7M 42.4% | $940.8M 41.8% | $880.5M 40.5% | $951.2M 45.6% | $880.9M 45.2% | $966.6M 45.1% | $1.03B 46.2% | $1.13B 49.0% | $1.16B 49.1% |
| Research & Development | $57.6M 2.6% | $58.4M 2.6% | $58.5M 2.6% | $55.5M 2.6% | $57.8M 2.8% | $55.3M 2.8% | $53.5M 2.5% | $61.1M 2.7% | $67.6M 2.9% | $71.9M 3.0% |
| Selling, General & Admin | $425.0M 19.1% | $430.1M 19.1% | $409.6M 18.2% | — | — | — | — | — | — | — |
| Operating Income | $96.6M 4.3% | $199.3M 8.8% | $227.0M 10.1% | $182.3M 8.4% | $239.9M 11.5% | $176.0M 9.0% | $243.8M 11.4% | — | — | — |
| Interest Expense | $73.2M 3.3% | $76.5M 3.4% | $78.5M 3.5% | $71.4M 3.3% | $67.9M 3.3% | $61.2M 3.1% | $62.6M 2.9% | $68.0M 3.0% | $69.2M 3.0% | $71.8M 3.0% |
| Other Income (Expense), net | $200K 0.0% | -$1.9M -0.1% | -$800K -0.0% | $13.2M 0.6% | $1.2M 0.1% | -$5.4M -0.3% | -$1.5M -0.1% | $1.4M 0.1% | $17.4M 0.8% | -$3.2M -0.1% |
| Pretax Income | $23.6M 1.1% | $120.9M 5.4% | $147.7M 6.6% | $124.1M 5.7% | $147.1M 7.0% | $87.3M 4.5% | -$390.3M -18.2% | $163.8M 7.3% | -$52.9M -2.3% | $219.9M 9.3% |
| Income Tax Expense | -$1.8M -0.1% | $22.3M 1.0% | $33.0M 1.5% | $24.6M 1.1% | $29.3M 1.4% | $19.7M 1.0% | -$18.1M -0.8% | $60.5M 2.7% | -$58.6M -2.5% | $41.2M 1.7% |
| Net Income | $25.4M 1.1% | $98.6M 4.4% | $114.7M 5.1% | $99.5M 4.6% | $117.8M 5.6% | $67.6M 3.5% | -$372.2M -17.4% | $103.3M 4.6% | $5.7M 0.2% | $178.7M 7.6% |
| Per Share | ||||||||||
| EPS (Basic) | $0.53 | $1.98 | $2.24 | $1.87 | $2.17 | $1.25 | $-6.88 | $1.90 | $0.10 | $3.02 |
| EPS (Diluted) | $0.53 | $1.97 | $2.21 | $1.85 | $2.13 | $1.24 | $-6.88 | $1.90 | $0.10 | $2.99 |
| Weighted Avg Shares (Basic) | 47.5M | 49.7M | 51.2M | 53.1M | 54.4M | 54.3M | 54.1M | 54.4M | 57.3M | 59.2M |
| Weighted Avg Shares (Diluted) | 47.6M | 50.1M | 51.8M | 53.6M | 55.2M | 54.6M | 54.1M | 54.5M | 57.5M | 59.7M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
Free-cash-flow coverage unavailable. Last year: $29M dividends + $90M buybacks = $120M returned.
1 consecutive years of dividend increases · 8%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 1%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
$220M of principal comes due within a year. Scheduled principal only (excludes interest & revolver draws). As of 2015-03-31 (10-Q).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~5.3% on $1.4B of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-08-05
No standout strengths flagged.
Where each multiple sits in its own 14-yr range · 52th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 38.5× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 53.8 | 54.9 | 54.8 | 54.4 | 59.5 | 58.2 | 57.6 | 58.4 |
| Gross Profit | 46.2 | 45.1 | 45.2 | 45.6 | 40.5 | 41.8 | 42.4 | 41.6 |
| R&D | 2.7 | 2.5 | 2.8 | 2.8 | 2.6 | 2.6 | 2.6 | 2.6 |
| SG&A | — | — | — | — | — | 18.2 | 19.1 | 19.1 |
| Operating Income | — | 11.4 | 9.0 | 11.5 | 8.4 | 10.1 | 8.8 | 4.3 |
| Income Tax | 2.7 | -0.8 | 1.0 | 1.4 | 1.1 | 1.5 | 1.0 | -0.1 |
| Net Income | 4.6 | -17.4 | 3.5 | 5.6 | 4.6 | 5.1 | 4.4 | 1.1 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on EPC: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.